Greatbatch and Boston Sci sign partnership; FDA clears EndoSerter eye device;

> Boston Scientific and Greatbatch Medical have signed a new five-year partnership to develop new product lines. Greatbatch release

> Ocular Systems, a North Carolina human tissue establishment and device maker, has received FDA clearance for its corneal transplant device, EndoSerter. The device administers replacement cells to the eye during corneal transplant surgery. OSI release

> Spanish surgical equipment manufacturer Oiarso-Bexen is expanding its facilities to increase its R&D focus and reach a broader global audience. The company currently has three plants: two in northern Spain and one in Kunshan, China. Article

> Surgical instrument maker Stereotaxis said Tuesday that Joseph Keegan, president and CEO of ForteBIO was elected to its board of directors. News

> In a study done by the Mayo Clinic, patients receiving stents are more likely to develop clots before 7 a.m. than any other time of the day. The researchers believe the evidence is tied to the body's circadian rhythms. Item

> ViewRay received FDA clearance to commercialize its MRI-guided radiation therapy. Article

And Finally... University of Rochester professor Jannick Rolland has developed a probe that can determine the malignancy of skin lesions without removing the lesion and sending it to a lab. "My hope is that, in the future, this technology could remove significant inconvenience and expense from the process of skin lesion diagnosis," Rolland says. Release

Suggested Articles

The ADDF announced its second round of research awards, with a total of $6 million in new funding for diagnostic tests.

Takeda teamed up with Enzyre to develop an at-home diagnostic device that will help people with hemophilia determine their own coagulation status.

Foundation Medicine received a diagnostic approval from the FDA for selecting HR+/HER2- breast cancer patients for treatment with Novartis' Piqray.